Methotrexate for Injection (preservative free)
Audience: Oncologists, dermatologists, rheumatologists, and other healthcare
professionals
[Posted 12/13/2005] FDA and Bedford Laboratories, a division of Ben Venue
Laboratories, Inc., Bedford, Ohio, announced that it is voluntarily
recalling one lot of Methotrexate for Injection (preservative free), USP 1
gram per vial (NDC 55390-143-01), Lot # 859142, exp 09/07, because the
active drug substance ("ADS") used to manufacture Lot # 859142, contained
low levels of ethylene glycol. Preservative-free methotrexate is the only
formulation that is acceptable for intrathecal administration. Healthcare
professionals and suppliers should not distribute these vials and should
contact Bedford Laboratories for return instructions. Consumers that have
received this product and have questions should contact their physicians.
[December 8, 2005 - Press Release - Bedford Laboratories]
I wish you all and your family a healthy end of the year.
From over the atlantic
Love and greetings from Belgium
Wil
Newsgroup Spambuster - 17 Dec 2005 00:38 GMT
Thanks, Wil, for this update, it is much appreciated.
How are YOU doing these days? How is the family?
Donna G
Gaetan Michiels - 25 Dec 2005 18:52 GMT
To all my ASA friends,
I wish you a Merry Christmas and a Happy New Year.
I was doing very well on 15 mg MTX and 3 mg Medrol , but suddenly my RA was
worsening very badly. All my joints are now very painful. My home doc give
me an injection with mobic but it did not help at all. My RD suggest to up
the medrol to 6 mg. Let's hope that can block the inflammation and the pain.
RA seems to think he is funny
Not exactly my idea of fun!
So, that's my RA-Christmas gift.
Greetings from Belgium
Wil
> Thanks, Wil, for this update, it is much appreciated.
>
> How are YOU doing these days? How is the family?
>
> Donna G